These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24876781)

  • 1. Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities.
    Alawneh KM; Khassawneh BY; Ayesh MH; Smadi M
    Ther Clin Risk Manag; 2014; 10():363-6. PubMed ID: 24876781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of CDAI and SDAI indices in comparison to DAS-28 index in Moroccan patients with rheumatoid arthritis.
    Slama IB; Allali F; Lakhdar T; El Kabbaj S; Medrare L; Ngeuleu A; Rkain H; Hajjaj-Hassouni N
    BMC Musculoskelet Disord; 2015 Sep; 16():268. PubMed ID: 26420567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
    Dhaon P; Das SK; Srivastava R; Dhakad U
    Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: an Indian experience.
    Singh H; Kumar H; Handa R; Talapatra P; Ray S; Gupta V
    Arthritis; 2011; 2011():146398. PubMed ID: 22242205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience.
    Singh H; Tanwar VS; Kalra A; Saini A; Arora S; Govil N
    Reumatismo; 2022 Sep; 74(2):. PubMed ID: 36101988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.
    Ranganath VK; Maranian P; Elashoff DA; Woodworth T; Khanna D; Hahn T; Sarkisian C; Kremer JM; Furst DE; Paulus HE
    Rheumatology (Oxford); 2013 Oct; 52(10):1809-17. PubMed ID: 23813577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of clinical disease activity index (CDAI) to evaluate the disease activity of rheumatoid arthritis patients in Sri Lanka: A prospective follow up study based on newly diagnosed patients.
    Dissanayake K; Jayasinghe C; Wanigasekara P; Dissanayake J; Sominanda A
    PLoS One; 2022; 17(11):e0278285. PubMed ID: 36445922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
    Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hip score and disease activity correlation in patients with rheumatoid arthritis after total hip arthroplasty.
    Wakabayashi H; Hasegawa M; Yoshida K; Nishioka K; Sudo A
    Int Orthop; 2013 Jul; 37(7):1245-50. PubMed ID: 23640680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
    Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
    J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
    Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Hetland ML
    J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis.
    Palamar D; Er G; Terlemez R; Ustun I; Can G; Saridogan M
    Clin Rheumatol; 2017 Oct; 36(10):2201-2208. PubMed ID: 28721628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T; Swearingen CJ; Bergman M; Yazici Y
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.
    Muñoz JGB; Giraldo RB; Santos AM; Bello-Gualteros JM; Rueda JC; Saldarriaga EL; Angarita JI; Arias-Correal S; Vasquez AY; Londono J
    Clin Rheumatol; 2017 May; 36(5):1143-1148. PubMed ID: 28013433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.
    Eissa M; El Shafey A; Hammad M
    Clin Rheumatol; 2017 Oct; 36(10):2217-2224. PubMed ID: 28534075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis.
    Ciurtin C; Jones A; Brown G; Sin FE; Raine C; Manson J; Giles I
    Eur Radiol; 2019 Nov; 29(11):6345-6354. PubMed ID: 31028442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the patient-reported outcome instruments determine disease activity in rheumatoid arthritis?
    Durmus B; Altay Z; Baysal O; Ersoy Y; Erdal A; Cevik R; Ardicoglu O; Tekeoglu I; Yildirim K; Sarac AJ; Kamanli A; Karatay S; Nas K; Kaya A; Senel K; Gur A; Ugur M; Ozgocmen S
    Bratisl Lek Listy; 2011; 112(10):555-61. PubMed ID: 21954539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
    Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
    Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
    Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.